| Followers | 141 |
| Posts | 5785 |
| Boards Moderated | 0 |
| Alias Born | 06/09/2020 |
Sunday, January 16, 2022 4:49:09 PM
I have a hard time though believing, that talking at a big conference like that, could "slip under the radar" regarding MB and his calendar. Such an event must be coordinated with NWBO especially if it is depending on journal having been published beforehand.
When they first registered a long time ago, they knew they were going to speak about "trial challenges". Topic generic worded. But since we got the "coming months" signal some months before the registration was public in beginning of September, they MUST have believed, they would be OUT of the quiet period, when the conference "hit".
To do the talk, MB needed for TLD and publication to have happened, in order to speak about the challenges.
He cancelled very late. Two days after he should've gotten the reminder about him being pushed. One can read something into that, and one can choose not to. I believe though, that it (TLD) remained a possibility and they left the "door open", just in case and ended cancelling very late.
When they first registered a long time ago, they knew they were going to speak about "trial challenges". Topic generic worded. But since we got the "coming months" signal some months before the registration was public in beginning of September, they MUST have believed, they would be OUT of the quiet period, when the conference "hit".
To do the talk, MB needed for TLD and publication to have happened, in order to speak about the challenges.
He cancelled very late. Two days after he should've gotten the reminder about him being pushed. One can read something into that, and one can choose not to. I believe though, that it (TLD) remained a possibility and they left the "door open", just in case and ended cancelling very late.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
